Search results for "Cardiopatía coronaria"

showing 6 items of 6 documents

Undetected coronary artery disease in apparently healthy athletes

2019

UEM1901 5.864 JCR (2019) Q1, 18/138 Cardiac & Cardiovascular Systems 1.459 SJR (2019) Q1, 58/362 Cardiology and Cardiovascular Medicine; Q2, 36/104 Epidemiology No data IDR 2019 UEM

AdultMaleCoronary angiographymedicine.medical_specialtyEpidemiologyHealth StatusEnfermedad cardiovascularMEDLINECoronary Artery DiseaseCoronary AngiographyCoronary artery diseaseYoung AdultRisk FactorsAtletaInternal medicineHumansMedicineYoung adultcoronary artery disease athletes sportbiologybusiness.industryAthletesCoronary arteriosclerosisAtletasbiology.organism_classificationmedicine.diseaseDeath Sudden CardiacAthletesCardiologyFemaleCardiopatía coronariasportCardiology and Cardiovascular MedicinebusinessEuropean Journal of Preventive Cardiology
researchProduct

An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes.

2017

Background: Information about the impact of frailty in patients with acute coronary syndromes (ACS) is scarce. No study has assessed the prognostic impact of frailty as measured by the FRAIL scale in very elderly patients with ACS. Methods: The prospective multicenter LONGEVO-SCA registry included unselected patients with ACS aged 80 years or older. A comprehensive geriatric assessment was performed during hospitalization, including frailty assessment by the FRAIL scale. The primary endpoint was mortality at 6 months. Results: A total of 532 patients were included. Mean age was 84.3 years, 61.7% male. Most patients had positive troponin levels (84%) and high GRACE risk score values (mean 16…

Background informationMalemedicine.medical_specialtyTime FactorsFrail ElderlyEnfermedad cardiovascularAncianoComorbidityKaplan-Meier Estimate030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineInternal medicineCause of DeathClinical endpointPrevalenceMedicineHumansIn patient030212 general & internal medicineProspective StudiesRegistriesAcute Coronary SyndromeGeneral NursingProportional Hazards ModelsAged 80 and overFramingham Risk ScoreEjection fractionbiologyFrailtybusiness.industryHealth PolicyMortality rateGeriatric assessmentGeneral MedicinePrognosisTroponinSurvival AnalysisSpainbiology.proteinCardiopatía coronariaFemaleGeriatrics and GerontologybusinessAncianosJournal of the American Medical Directors Association
researchProduct

Non-coding RNAs and Coronary Artery Disease

2020

Coronary artery disease (CAD) is the leading death cause worldwide. Non-coding RNA (ncRNA) are key regulators of genetic expression and thus can affect directly or indirectly the development and progression of different diseases. ncRNA can be classified in several types depending on the length or structure, as long non-coding RNA (lncRNA), microRNA (miRNA) and circularRNA (circRNA), among others. These types of RNA are present within cells or in circulation, and for this reason they have been used as biomarkers of different diseases, therefore revolutionizing precision medicine. Recent research studied the capability of circulating ncRNA to inform about CAD presence and predict the outcome …

Enfermedad cardiovascularRNABiomarkerDiseaseComputational biologyGenética humanaBiologyNon-coding RNAPrecision medicinemedicine.diseaseARNCoronary artery disease (CAD)Coronary artery disease03 medical and health scienceslncRNA0302 clinical medicineBiomarker; Coronary artery disease (CAD); circRNA; lncRNA; miRNAGene expressionmicroRNAmedicineBiomarker (medicine)Cardiopatía coronariacircRNA030212 general & internal medicinemiRNA
researchProduct

Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome.

2019

Background The Charlson's is the most used comorbidity index. It comprises 19 comorbidities, some of which are infrequent in elderly patients with acute coronary syndrome (ACS), while some others are manifestations of cardiac disease rather than comorbidities. Our goal was to simplify comorbidity assessment in elderly non-ST-segment elevation ACS patients. Methods The study group consisted of 1 training (n = 920, 76 ± 7 years) and 1 testing (n = 532; 84 ± 4 years) cohorts. The end-point was all-cause mortality at 1-year follow-up. Comorbidities were assessed selecting those medical disorders other than cardiac disease that were independently associated with mortality by multivariable analys…

Malemedicine.medical_specialtyAcute coronary syndromeTime FactorsAnemiaEnfermedad cardiovascularAncianoCharlson indexDiseaseComorbidityKaplan-Meier Estimate030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineDiabetes mellitusCause of Deathmental disordersInternal MedicinemedicineHumans030212 general & internal medicineHospital MortalityProspective StudiesAcute Coronary SyndromeAgedProportional Hazards ModelsAged 80 and overbusiness.industrymedicine.diseaseComorbiditySpainRisk stratificationCohortCardiopatía coronariaFemalebusinessAncianosEuropean journal of internal medicine
researchProduct

Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The “Bayes' Syndrome-HF” study

2018

Advanced interatrial block (IAB) is characterized by a prolonged (≥120 ms) and bimodal P wave in the inferior leads. The association between advanced IAB and atrial fibrillation (AF) is known as “Bayes' Syndrome”, and there is scarce information about it in heart failure (HF). We examined the prevalence of IAB and whether advanced IAB could predict new-onset AF and/or stroke in HF patients. Methods and results: The prospective observational “Bayes' Syndrome-HF” study included consecutive outpatients with chronic HF. The primary endpoints were new-onset AF, ischemic stroke, and the composite of both. A secondary endpoint included all-cause death alone or in combination with the primary endpo…

Malemedicine.medical_specialtyAll-cause deathEnfermedad cardiovascularAdvanced interatrial blockNew-onset atrial fibrillationHeart failure030204 cardiovascular system & hematologyFibrilación auricularBrain IschemiaElectrocardiography03 medical and health sciences0302 clinical medicinePredictive Value of TestsInternal medicineAtrial FibrillationmedicineClinical endpointHumansInteratrial BlockSinus rhythmProspective Studies030212 general & internal medicineStrokeAgedSistema cardiovascularAged 80 and overHeart FailureProportional hazards modelbusiness.industryAtrial fibrillationInteratrial BlockSyndromeMiddle Agedmedicine.diseaseStrokeHeart failureCardiologyFemaleCardiopatía coronariaObservational studyInfarto de miocardioCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesInternational Journal of Cardiology
researchProduct

Cardiometabolic non-response to aerobic exercise: Identifying subclinical ischaemic coronary disease

2019

Sin financiación 5.864 JCR (2019) Q1, 18/138 Cardiac & Cardiovascular Systems 1.459 SJR (2019) Q1, 58/362 Cardiology and Cardiovascular Medicine; Q2, 36/104 Epidemiology No data IDR 2019 UEM

medicine.medical_specialtyEpidemiologyEnfermedad cardiovascularCardiologyMEDLINECardiometabolic responseCoronary Artery DiseaseCoronary diseaseCoronary artery diseaseInternal medicineDiabetes mellitusmedicineHumansAerobic exerciseExerciseCardiometabolic response aerobic exercise coronary disease.Subclinical infectionMetabolismobusiness.industrymedicine.diseaseaerobic exerciseDiabetes Mellitus Type 2coronary disease.Cardiovascular DiseasesCardiologyCardiopatía coronariaCardiology and Cardiovascular MedicinebusinessEuropean Journal of Preventive Cardiology
researchProduct